Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Humoral immunity to human metapneumovirus infection in adults.

Falsey AR, Hennessey PA, Formica MA, Criddle MM, Biear JM, Walsh EE.

Vaccine. 2010 Feb 10;28(6):1477-80. doi: 10.1016/j.vaccine.2009.11.063. Epub 2009 Dec 8.

2.

Longitudinal course of human metapneumovirus antibody titers and reinfection in healthy adults.

Okamoto M, Sugawara K, Takashita E, Muraki Y, Hongo S, Nishimura H, Matsuzaki Y.

J Med Virol. 2010 Dec;82(12):2092-6. doi: 10.1002/jmv.21920.

PMID:
20981798
3.

Microneutralization assay for the measurement of neutralizing antibodies to human metapneumovirus.

Falsey AR, Formica MA, Walsh EE.

J Clin Virol. 2009 Dec;46(4):314-7. doi: 10.1016/j.jcv.2009.09.020. Epub 2009 Oct 8.

4.

Experimental infection of adults with recombinant wild-type human metapneumovirus.

Talaat KR, Karron RA, Thumar B, McMahon BA, Schmidt AC, Collins PL, Buchholz UJ.

J Infect Dis. 2013 Nov 15;208(10):1669-78. doi: 10.1093/infdis/jit356. Epub 2013 Aug 1.

5.

Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in mice.

Lévy C, Aerts L, Hamelin MÈ, Granier C, Szécsi J, Lavillette D, Boivin G, Cosset FL.

Vaccine. 2013 Jun 7;31(25):2778-85. doi: 10.1016/j.vaccine.2013.03.051. Epub 2013 Apr 11.

PMID:
23583815
6.

Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies.

Alvarez R, Harrod KS, Shieh WJ, Zaki S, Tripp RA.

J Virol. 2004 Dec;78(24):14003-11.

7.
8.

[Analysis of neutralizing activity of sera from 0 to 6 years old children in Chongqing area against human metapneumovirus].

Zhang Q, Yang XQ, Zhao XD.

Zhonghua Er Ke Za Zhi. 2007 Jun;45(6):432-6. Chinese.

PMID:
17880789
9.

Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.

Wen SC, Schuster JE, Gilchuk P, Boyd KL, Joyce S, Williams JV.

J Virol. 2015 Sep;89(17):8713-26. doi: 10.1128/JVI.00670-15. Epub 2015 Jun 10.

10.

A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge.

Russell CJ, Jones BG, Sealy RE, Surman SL, Mason JN, Hayden RT, Tripp RA, Takimoto T, Hurwitz JL.

Virology. 2017 Sep;509:60-66. doi: 10.1016/j.virol.2017.05.021. Epub 2017 Jun 9.

PMID:
28605636
11.

T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection.

Kolli D, Bataki EL, Spetch L, Guerrero-Plata A, Jewell AM, Piedra PA, Milligan GN, Garofalo RP, Casola A.

J Virol. 2008 Sep;82(17):8560-9. doi: 10.1128/JVI.00699-08. Epub 2008 Jun 18.

12.

The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness.

Skiadopoulos MH, Biacchesi S, Buchholz UJ, Riggs JM, Surman SR, Amaro-Carambot E, McAuliffe JM, Elkins WR, St Claire M, Collins PL, Murphy BR.

J Virol. 2004 Jul;78(13):6927-37.

13.

Immunogenicity and efficacy of two candidate human metapneumovirus vaccines in cynomolgus macaques.

Herfst S, Schrauwen EJ, de Graaf M, van Amerongen G, van den Hoogen BG, de Swart RL, Osterhaus AD, Fouchier RA.

Vaccine. 2008 Aug 5;26(33):4224-30. doi: 10.1016/j.vaccine.2008.05.052. Epub 2008 Jun 6.

PMID:
18585830
14.

A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus.

Schuster JE, Cox RG, Hastings AK, Boyd KL, Wadia J, Chen Z, Burton DR, Williamson RA, Williams JV.

J Infect Dis. 2015 Jan 15;211(2):216-25. doi: 10.1093/infdis/jiu307. Epub 2014 May 26.

15.

High seroprevalence of neutralizing capacity against human metapneumovirus in all age groups studied in Bonn, Germany.

Lüsebrink J, Wiese C, Thiel A, Tillmann RL, Ditt V, Müller A, Schildgen O, Schildgen V.

Clin Vaccine Immunol. 2010 Mar;17(3):481-4. doi: 10.1128/CVI.00398-09. Epub 2009 Dec 30.

16.

Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats.

Cseke G, Wright DW, Tollefson SJ, Johnson JE, Crowe JE Jr, Williams JV.

J Virol. 2007 Jan;81(2):698-707. Epub 2006 Oct 18.

17.

Experimental infection of macaques with human metapneumovirus induces transient protective immunity.

van den Hoogen BG, Herfst S, de Graaf M, Sprong L, van Lavieren R, van Amerongen G, Yüksel S, Fouchier RA, Osterhaus AD, de Swart RL.

J Gen Virol. 2007 Apr;88(Pt 4):1251-9.

PMID:
17374769
18.

Generation of temperature-sensitive human metapneumovirus strains that provide protective immunity in hamsters.

Herfst S, de Graaf M, Schrauwen EJ, Sprong L, Hussain K, van den Hoogen BG, Osterhaus AD, Fouchier RA.

J Gen Virol. 2008 Jul;89(Pt 7):1553-62. doi: 10.1099/vir.0.2008/002022-0.

PMID:
18559924
19.

A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo.

Williams JV, Chen Z, Cseke G, Wright DW, Keefer CJ, Tollefson SJ, Hessell A, Podsiad A, Shepherd BE, Sanna PP, Burton DR, Crowe JE Jr, Williamson RA.

J Virol. 2007 Aug;81(15):8315-24. Epub 2007 May 23.

20.

A duplex recombinant viral nucleoprotein microbead immunoassay for simultaneous detection of seroresponses to human respiratory syncytial virus and metapneumovirus infections.

Zhang Y, Brooks WA, Goswami D, Rahman M, Luby SP, Erdman DD.

J Virol Methods. 2014 Sep;206:55-62. doi: 10.1016/j.jviromet.2014.05.008. Epub 2014 May 23.

PMID:
24859050

Supplemental Content

Support Center